Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Combining drugs with radiotherapy

Prof John Staffurth - Cardiff University, Cardiff, UK
Combining drugs with radiotherapy ( Prof John Staffurth - Cardiff University, Cardiff, UK )
5 Oct 2016

A novel biomarker for paediatic tumours

Dr Kathleen Birley - UCL Institute of Child Health, London, UK
A novel biomarker for paediatic tumours ( Dr Kathleen Birley - UCL Institute of Child Health, London, UK )
5 Oct 2016

Paediatric ALL with brain metastases

Dr Christina Halsey - University of Glasgow, Glasgow, UK
Paediatric ALL with brain metastases ( Dr Christina Halsey - University of Glasgow, Glasgow, UK )
5 Oct 2016

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK
miRNA screening for germ cell tumours ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )
5 Oct 2016

ALK mutations in paediatric tumours

Dr Suzanne Turner - Cambridge University, Cambridge, UK
ALK mutations in paediatric tumours ( Dr Suzanne Turner - Cambridge University, Cambridge, UK )
5 Oct 2016

NCI’s precision medicine initiatives

Dr Shakun Malik - National Cancer Institute, USA
NCI’s precision medicine initiatives ( Dr Shakun Malik - National Cancer Institute, USA )
5 Oct 2016

Omics, early detection and novel therapies: Q & A

Dr Murrell and Dr Pardo
Omics, early detection and novel therapies: Q & A ( Dr Murrell and Dr Pardo )
5 Oct 2016

Omics, early detection and novel therapies: Metabolomics

Dr Olivier Pardo - Imperial College London, London, UK
Omics, early detection and novel therapies: Metabolomics ( Dr Olivier Pardo - Imperial College London, London, UK )
5 Oct 2016

Omics, early detection and novel therapies: Epigenetic studies

Dr Adele Murrell - University of Bath, Bath, UK
Omics, early detection and novel therapies: Epigenetic studies ( Dr Adele Murrell - University of Bath, Bath, UK )
5 Oct 2016

We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK
We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Dr Mary O’Brien - The Royal Marsden NHS Foundation Trust, London, UK )
5 Oct 2016

We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Prof Gordon McVie - King's College London, London, UK
We should not use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies ( Prof Gordon McVie - King's College London, London, UK )
5 Oct 2016

Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers?

Dr Mark Miller - UCSF, San Francisco, USA
Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers? ( Dr Mark Miller - UCSF, San Francisco, USA )
29 Sep 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation